These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6707938)

  • 1. Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Apr; 229(1):214-7. PubMed ID: 6707938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of pentazocine antinociception by tripelennamine in the rat.
    Yeh SY
    J Pharmacol Exp Ther; 1985 Dec; 235(3):683-9. PubMed ID: 4078730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Oct; 231(1):97-101. PubMed ID: 6541694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
    O'Callaghan JP; Holtzman SG
    J Pharmacol Exp Ther; 1975 Mar; 192(3):497-505. PubMed ID: 1168252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive activity of salmon calcitonin injected intraventricularly in mice: modulation of morphine antinociception.
    Welch SP; Cooper CW; Dewey WL
    J Pharmacol Exp Ther; 1986 Apr; 237(1):54-8. PubMed ID: 3958973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihistaminic-opioid combination: effect on locomotor activity in mice.
    Sansone M
    Pol J Pharmacol Pharm; 1988; 40(5):515-23. PubMed ID: 3253717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between H1-antagonists and opioids: a drug discrimination study.
    Suzuki T; Mori T; Tsuji M; Misawa M; Onodera K
    Psychopharmacology (Berl); 1997 Jun; 131(4):346-53. PubMed ID: 9226736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
    Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
    J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
    Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: involvement of calcium channels.
    Biala G; Weglinska B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):15-21. PubMed ID: 16202496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels.
    Shannon HE; Su TP
    Pharmacol Biochem Behav; 1982 Oct; 17(4):789-95. PubMed ID: 6294681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antinociceptive effect of morphine is reversed by okadaic acid in morphine-naive but not in morphine-tolerant mice.
    Ocaña M; Entrena JM; Baeyens JM; Del Pozo E
    Pharmacol Biochem Behav; 2007 Jan; 86(1):21-6. PubMed ID: 17234262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripelennamine fails to enhance the morphine-like stimulus effects of pentazocine.
    Oliveto AH; Slifer BL; Dykstra LA
    Pharmacol Biochem Behav; 1988 Feb; 29(2):397-401. PubMed ID: 3362933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of antinociception induced by foot shock and morphine.
    Snow AE; Dewey WL
    J Pharmacol Exp Ther; 1983 Oct; 227(1):42-50. PubMed ID: 6312021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-tolerance and cross-sensitization between morphine analgesia and naloxone-sensitive and cimetidine-sensitive stress-induced analgesia.
    Weinstein IJ; Hough LB; Gogas KR
    J Pharmacol Exp Ther; 1988 Jan; 244(1):253-8. PubMed ID: 3336002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacology of pentazocine and tripelennamine (T's and Blues).
    Lange WR; Jasinski DR
    Adv Alcohol Subst Abuse; 1986; 5(4):71-83. PubMed ID: 3751735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of tripelennamine alone and in combination with opiates to produce antinociception in mice.
    Hui FW; Sun CJ; Tocus EC; Hanig JP
    Life Sci; 1983 Apr; 32(14):1531-8. PubMed ID: 6835002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between pentazocine and tripelennamine on autonomic and nociceptive measures in the dog.
    Vaupel DB
    Pharmacol Biochem Behav; 1989 May; 33(1):245-51. PubMed ID: 2780781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.